

The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.
Apply to participate in a study of an investigational medication for schizophrenia
Apply to participate in a study of an investigational pain medication following a bunion removal
Apply to participate in a study of an investigational medication for Bipolar Disorder
Take a self assessment to see if you qualify for a no cost mental health assessment with our medical team